Investigation and potential lawsuits against Bayer for its drug Baycol.
Baycol is designed to aid patients in lowering cholesterol. According to the Food and Drug Administration ('FDA'), Bayer voluntarily removed Baycol from the US market because of reports of sometimes fatal rhabdomyolysis, a severe muscle adverse reaction from this anti-cholesterol product. The FDA reported at least 31 deaths due to severe rhabdomyolysis associated with use of Baycol.
Rhabdomyolysis is a condition that results in muscle cell breakdown and release of the contents of muscle cells into the bloodstream. Symptoms of rhabdomyolysis include muscle pain, weakness, tenderness, malaise, fever, dark urine, nausea, and vomiting. The pain may involve specific groups of muscles or may be generalized throughout the body.
Do not change medications without first consulting your doctor.
Defendant Details
Name (Stock Symbol)
Brief Description
Bayer AG
Bayer AG manufactures pharmaceuticals and consumer products.